Delivery Order SPE2DB24D2018-SPE2DB26FWRN1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,614.63 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, executed on August 25, 2025, with completion scheduled for August 26, 2025, operates under firm fixed pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of 60 tablets of Eliquis 5 mg, a widely-prescribed anticoagulant medication. This competitively awarded, firm fixed-price delivery order has a ceiling value of $57,216.01 and is scheduled for completion by October 21, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,601.44 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,895.05 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, executed on May 20, 2025, with completion by May 21, 2025, was issued under a firm fixed-price arrangement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.78 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a prescription anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,476.65 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,744.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains operations as a critical vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,703.75 delivery order for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. This firm fixed-price delivery order, issued on August 15, 2025, with completion scheduled for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was awarded competitively with no...
- The Defense Logistics Agency awarded a delivery order valued at $4,017.91 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award conditions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB26FWRN1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and utilized firm fixed-price pricing with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio with the DLA demonstrates its significant role as a critical vendor for federal medical procurement, supplying medications across multiple therapeutic domains including specialty pharmaceuticals, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/24/25 |